Nagata Koh, Shimada Takako, Eishi Chiaki, Nishi Masaki, Murakami Toru, Ohashi Kazuaki, Kajimura Itsuki, Miura Kiyonori
Obstetrics and Gynecology, Nagasaki University Hospital, Nagasaki, Japan.
Int Med Case Rep J. 2023 Mar 7;16:117-122. doi: 10.2147/IMCRJ.S395511. eCollection 2023.
We report a case of dysgerminoma in a 22-year-old woman diagnosed with chromosomal abnormality, balanced translocation 46X,t(X:1)(q22;q21). She had received hormone replacement therapy for 7 years for primary amenorrhea. She visited a primary care physician because of lower abdominal distension, and a large tumor in the pelvis was discovered. She was admitted to our hospital for further examination of the pelvic tumor. She underwent laparotomy and was diagnosed with stage IIIA1 dysgerminoma (pT3apN0pM0) of the left ovary. Young female patients without the Y chromosome who are treated for primary amenorrhea may also develop malignant germ cell tumors; therefore, gynecologists should provide hormone replacement therapy and periodic pelvic evaluation.
我们报告一例22岁女性的无性细胞瘤病例,该患者被诊断为染色体异常,即平衡易位46,X,t(X;1)(q22;q21)。她因原发性闭经接受了7年的激素替代治疗。她因下腹胀就诊于初级保健医生,随后发现盆腔有一个大肿瘤。她被收入我院进一步检查盆腔肿瘤。她接受了剖腹手术,被诊断为左卵巢IIIA1期无性细胞瘤(pT3apN0pM0)。因原发性闭经接受治疗的无Y染色体年轻女性患者也可能发生恶性生殖细胞肿瘤;因此,妇科医生应提供激素替代治疗并进行定期盆腔评估。